Abstract: Novel selective estrogen receptor degraders (SERDs) according to the formula: and pharmaceutically acceptable salt thereof and pharmaceutical compositions thereof, wherein R is selected from or.
| # | Name | Date |
|---|---|---|
| 1 | 202317061090-STATEMENT OF UNDERTAKING (FORM 3) [11-09-2023(online)].pdf | 2023-09-11 |
| 2 | 202317061090-REQUEST FOR EXAMINATION (FORM-18) [11-09-2023(online)].pdf | 2023-09-11 |
| 3 | 202317061090-POWER OF AUTHORITY [11-09-2023(online)].pdf | 2023-09-11 |
| 4 | 202317061090-FORM 18 [11-09-2023(online)].pdf | 2023-09-11 |
| 5 | 202317061090-FORM 1 [11-09-2023(online)].pdf | 2023-09-11 |
| 6 | 202317061090-DECLARATION OF INVENTORSHIP (FORM 5) [11-09-2023(online)].pdf | 2023-09-11 |
| 7 | 202317061090-COMPLETE SPECIFICATION [11-09-2023(online)].pdf | 2023-09-11 |
| 8 | 202317061090-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [11-09-2023(online)].pdf | 2023-09-11 |
| 9 | 202317061090-Proof of Right [24-11-2023(online)].pdf | 2023-11-24 |
| 10 | 202317061090-FORM 3 [11-03-2024(online)].pdf | 2024-03-11 |